Didem Ozkazanc
Istanbul, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies.
Journal: Journal of hematology & oncology
Published: August 31, 2022
An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-β1 and fingolimod therapy.
Journal: Journal of neuroimmunology
Published: March 25, 2020
Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
Journal: Frontiers in immunology
Published: July 15, 2019
Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 28, 2019
Engineering antigen-specific NK cell lines against the melanoma-associated antigen tyrosinase via TCR gene transfer.
Journal: European journal of immunology
Published: February 12, 2019
Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 Antibody.
Journal: Molecular pharmaceutics
Published: February 27, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026